Previous Article | Next Article ![]()
Eukaryotic Cell, April 2005, p. 694-702, Vol. 4, No. 4
1535-9778/05/$08.00+0 doi:10.1128/EC.4.4.694-702.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Biological Sciences, Hunter College, New York, New York
Received 6 November 2004/ Accepted 23 January 2005
|
|
|---|
|
|
|---|
When starved in the presence of a high concentration of other starving cells, a Dictyostelium cell responds in a typical manner upon receiving a pulse of cAMP; it releases a burst of cAMP to relay the signal to other starving cells, moves toward the source of cAMP, and expresses specific classes of genes required for the cell to undergo development (7-9, 11, 16, 28, 34, 36, 41). cAR1, a cell surface cAMP receptor, senses the cAMP (39). Binding of cAMP to cAR1 causes a transient influx of Ca2+ (27) and activates an associated heterotrimeric G protein. The Gß
subunit, with the assistance of a cytosolic protein called cytosol regulator of adenylyl cyclase (CRAC), transiently activates adenylyl cyclase, while the G
2 subunit activates guanylyl cyclase (20, 25, 40, 42).
The activation of this G protein signaling event and subsequent aggregation and development depends upon an 80-kDa secreted glycoprotein called conditioned medium factor (CMF) (15, 29). CMF is synthesized in actively dividing cells but not secreted until starvation. Since only starving cells can secrete and sense CMF, it is an ideal molecule for quorum sensing during development (22). When only a few cells are starving, CMF levels are low and preclude aggregation. Once a large number of cells are starving, the high levels of CMF released cause the initiation of aggregation. As can be expected, cells lacking CMF are unable to aggregate unless exogenous or recombinant CMF is added (42). Thus, CMF may coordinate the development of appropriate sized fruiting bodies by allowing aggregation only when most of the cells in a given area are starving, as determined by high levels of CMF.
CMF exerts control over development by regulating cAMP signaling through cAR1 (45). When at high cell density, and thus in the presence of high levels of CMF, cAMP binds to cAR1, activating its associated G protein. G
2 binds GTP and releases Gß
. These subunits then activate guanylyl and adenylyl cyclase, respectively. In the absence of CMF, cAMP can still bind to cAR1, and the activation of cAR1 can still cause G
2 to release GDP and bind GTP. However, activation of adenylyl and guanylyl cyclase is greatly inhibited. This inhibition of adenylyl and guanylyl cyclase can be removed by a 10-s exposure of CMF, showing that lack of CMF is the direct cause of inhibition. The presence or absence of CMF has no effect on the levels of cAR1- and cAMP-induced binding of GTP to membranes, arguing that the lack of CMF has no effect on the interaction between cAR1 and its G protein in vitro. Thus, CMF controls aggregation by regulating cAMP signaling at a point after G protein activation but before the activations of adenylyl and guanylyl cyclases. CMF accomplishes this by controlling the GTPase rate of G
2. We found that in lysates, approximately 250 molecules of GTP bind to a cell's membrane in response to a pulse of cAMP, regardless of whether CMF is present or absent (4, 45). After cAMP stimulation, GTP is hydrolyzed to GDP at a rate of approximately 240 molecules in 3 min in the absence of CMF. However, in the presence of CMF, the rate of GTP hydrolysis is drastically reduced to approximately 51 molecules in 3 min. Since lysates from cells lacking G
2 have no cAMP-stimulated GTP binding or hydrolysis (4), these results argue that quorum sensing through CMF is accomplished by controlling the cAMP-stimulated GTPase activity of G
2.
We have previously shown that CMF exerts its effect on cAR1 signaling by activating its own G protein signaling pathway, as opposed to its G protein-independent pathway (5). We demonstrated that CMF uses G
1 and Gß to control the activity of phospholipase C, which in turn regulates the cAMP-stimulated GTPase activity of G
2. In many organisms, the GTPase activity of G
proteins is regulated by RGS (regulator of G protein signaling) proteins. In turn, RGS proteins can be controlled by the levels of phosphatidic acid, a by-product of phospholipase D (30). This leads to the interesting possibility that phospholipase D may be involved in quorum sensing. In this report, we describe the role of a phospholipase D (PLD), PldB, in Dictyostelium development and present evidence that PldB is a negative regulator of quorum sensing.
|
|
|---|
Generation of pldB deletion mutant and overexpression mutant. To generate a deletion mutant of pldB, we replaced 719 nucleotides in the middle of the pldB gene with the blasticidin resistance marker under control of the actin 15 promoter. A partial cDNA clone of pldB obtained from the Dictyostelium genome project was digested with NdeI to remove part of the pldB coding region, and the ends were blunted. The plasmid carrying the blasticidin cassette (pBsr519) (35) was digested with BamHI to isolate the cassette. The ends of the blasticidin cassette were blunted; it was then ligated into the modified cDNA clone of pldB. The resulting plasmid contained 0.5 kbp of pldB, the blasticidin cassette replacing 719 nucleotides of pldB sequence, and 0.6 kbp of pldB sequence. For transformation, 10 µg of the plasmid was linearized with PvuI and gel purified with Geneclean (Bio 101, Vista, Calif.). The fragment was then used to transform Ax2 cells by following the procedure of Shaulsky et al. (37). Multiple clones with the same phenotypes were isolated, and the ones showing the strongest phenotypes were used for subsequent experiments. To generate an overexpression mutant, the pldB gene, isolated by PCR from genomic DNA, was placed under the control of the constitutively active actin 15 promoter by using the Gateway System (Invitrogen, Carlsbad, Calif.). The plasmid was used to transform Ax2 and pldB cells by following the procedure of Shaulsky et al. (37).
Antibody production and Western blots. The synthetic peptide GCFLIVYKKKKHDEDKPS from amino acids 30 to 47 of PldB was used to immunize a rabbit at Biosynthesis, Inc. (Lewisville, Tex.). Serum was collected 8 weeks after the second injection and purified by using the above peptide attached to agarose beads. Cells (106) were collected from different stages of development and boiled for 3 min in sodium dodecyl sulfate-polyacrylamide gel electrophoresis sample buffer in a final volume of 500 µl. A 20-µl aliquot was loaded onto a 10% polyacrylamide gel electrophoresis gel, and Western blots were done according to the method of Jain and Gomer (21).
Northern blotting and reverse transcription-PCR (RT-PCR). RNA was isolated from cells starved on filter pads at the times indicated with the Rneasy mini kit (QIAGEN, Inc., Valencia, Calif.) or Trizol reagent (Invitrogen). RNA was then run on an agarose gel, visualized by ethidium bromide staining, and transferred to a Hybond-N+ membrane (Amersham, Piscataway, N.J.). Northern blot analysis was performed following the procedure of Bishop et al. (3) with the following partial gene fragments as DNA probes: pldB (250 bp), cAR1 (710 bp), CRAC (616 bp), ACA (705 bp), and IG7 (368 bp). Blots with the same probe were incubated together in the same hybridization buffer and exposed to film for the same length of time in the same film cassette. Densitometry was performed by using a Molecular Dynamics personal densitometer SI.
RT-PCR was performed with the GeneAmp RNA PCR kit (Applied Biosystems, Foster City, Calif.) as per the manufacturer's directions. The upstream primer for pldB was 5'-CACCATTAGCTTCCCATTGTC-3', and the downstream primer was 5'-GGTGATCTTGCATTAGCATCCTC-3'. This set of primers provides a 170-bp product. RT-PCR was also performed on the IG7 gene as a control for the total amount of RNA used. The upstream primer was 5'-TTACATTTATTAGACCCGAAACCAAGCG-3', and the downstream primer was 5'TTCCCTTTAGACCTATGGACCTTAGCG-3'. This set of primers yields a 370-bp product. The PCR products were separated on a 2% agarose gel and visualized with ethidium bromide. Duplicate reactions were performed without reverse transcriptase to control for DNA contamination in the RNA preparation.
|
|
|---|
The pldB gene resides on chromosome 3, is 2,747 nucleotides long with one intron, and codes for a hypothetical protein of 867 amino acids. The translated protein contains the conserved regions found in all PLD1's including a pleckstrin homology (PH) domain, catalytic region I (CRI), CRII, a loop, CRIII, CRIV, and the C-terminal tail (12, 26). Overall, the protein shares 32% similarity and 21% identity with PLD1 from humans. Excluding the N terminus and loop domains, which vary widely from species to species, PldB has 51% similarity and 34% identity to PLD1 from humans. A comparison of catalytic regions of PldB with other PLDs is shown in Fig. 1.
![]() View larger version (34K): [in a new window] |
FIG. 1. Comparison of the predicted amino acid sequences of the catalytic regions of PldB (D. disc), human Pld1 (H. sap1), human Pld2 (H. sap2), and Drosophila melanogaster Pld (D. mela). Amino acid identities are in black boldface type, while amino acid similarities are in gray.
|
![]() View larger version (35K): [in a new window] |
FIG. 2. The expression of pldB is developmentally regulated. (A) A Northern blot of total cellular RNA isolated from Ax2 cells at 4-h intervals after starvation on filter pads was probed with a radiolabeled fragment of the pldB gene. (B) A Western blot of lysates from pldB cells and Ax2 cells taken at 4-h intervals after starvation on filter pads was probed with affinity-purified anti-PldB peptide antibodies.
|
|
View this table: [in a new window] |
TABLE 1. Effect of butanol on low-cell-density aggregationa
|
![]() View larger version (17K): [in a new window] |
FIG. 3. Construction of the pldB deletion mutant. (A) After homologous pairing between the linearized targeting vector, pldB construct, and the genomic pldB locus, homologous recombination in the regions labeled X replaces the endogenous pldB sequence with an exogenous sequence containing the blasticidin resistance cassette (Bsr), resulting in a deletion of the pldB gene. The cell lines produced by this event are resistant to blasticidin. Black box, gene; white box, blasticidin resistance cassette. (B) PCR was performed on DNA prepared from wild-type Ax2 cells, the gene disruption construct (pldB), and 9 blasticidin-resistant clones, and the resulting products were separated on an agarose gel. Primer pair 2-3 tests for the presence of the disruption construct in the genome, while primer pair 1-3 tests for proper insertion of the disruption construct in the pldB gene. Strains 1, 2, 3, 5, 6, 8, and 9 show proper integration of the disruption construct.
|
|
View this table: [in a new window] |
TABLE 2. Ability of mixed populations of wild-type and pldB cells to aggregate at low cell densitya
|
Since pldB gene activity normally blocks quorum sensing, we reasoned that cells overexpressing pldB should be unable to aggregate at high cell density. To test this, we created strains that overexpress pldB by introducing a plasmid-borne copy of the pldB gene constitutively expressed from the actin 15 promoter into both wild-type and pldB cells. RT-PCR was performed on RNA isolated from vegetative cells to confirm overexpression of pldB (Fig. 4). As expected, very little if any product is seen in the Ax2 wild-type or pldB cells (pldB is not expressed in vegetative cells). However, both Ax2 wild-type and pldB cells containing the overexpression plasmid show the presence of pldB mRNA. The same RNA samples were used to perform RT-PCR to monitor the expression of IG7 (a transcript used as an internal control) and demonstrate that the differences seen in expression of pldB were not due to differences in starting RNA amounts. In addition, Northern blots of vegetative Ax2 wild-type and pldB cells containing the overexpression plasmid identified a 2.8-kb band, corresponding to the full-length pldB transcript (data not shown). Thus, we were able to confirm overexpression of pldB. The effect of overexpressing pldB is shown in Table 3. In both wild-type and pldB cells overexpressing pldB, aggregation was inhibited even at 224 x 103 cells/cm2, the highest cell density examined. Addition of 0.1% butanol is able to partially reverse this inhibition and allow aggregation at 112 x 103 cells/cm2, suggesting that the inability to aggregate may be ameliorated by inhibition of PLD activity. In addition, exogenous CMF was unable to induce aggregation at a lower cell density, corroborating our previous results suggesting that pldB is involved in the cellular response to CMF. If pldB is a negative regulator of aggregation, then enhancing its activity would preclude aggregation at higher and higher cell densities; our data show that this is the case. Likewise, removing its activity would allow cells to aggregate at any density, including extremely low densities, which our data also show to occur. Taken together, these data suggest that pldB is a negative regulator of quorum sensing and lies in the CMF pathway.
![]() View larger version (40K): [in a new window] |
FIG. 4. Overexpression of pldB in wild-type and pldB cells. RNA from vegetative wild-type and pldB cells, with or without the pldB overexpression plasmid, were collected, and RT-PCR with pldB-specific primers was performed. Simultaneous reactions were performed with primers for the IG7 gene to ensure that equal amounts of total RNA were used in each of the samples.
|
|
View this table: [in a new window] |
TABLE 3. Effect of pldB expression on low-cell-density aggregationa
|
![]() View larger version (38K): [in a new window] |
FIG. 5. pldB cells form fruiting bodies with slightly elongated stalks. Wild-type Ax2 and pldB cells were plated with bacteria on agar. As the bacteria were consumed, development was triggered, and after 24 h, fruiting bodies formed. A side view of these fruiting bodies is shown. Bar, 1 mm.
|
![]() View larger version (77K): [in a new window] |
FIG. 6. pldB cells aggregate rapidly in submerged culture. Cells were starved at 224 x 103 cells/cm2 in PBM, and photos were taken 9 and 16 h later. Bar, 1 mm.
|
![]() View larger version (62K): [in a new window] |
FIG. 7. pldB cells develop rapidly on filter pads. Cells were deposited on filters and allowed to develop. Photos were taken at the indicated times. Bar, 3 mm.
|
![]() View larger version (50K): [in a new window] |
FIG. 8. car1 is expressed strongly and early in pldB cells. Northern blots of total cellular RNA isolated from wild-type Ax2 cells and pldB cells at 4-h intervals (A) or 1-h intervals (B) after starvation were probed with a radiolabeled fragment of the car1 gene. The same blots were stripped and reprobed with a radiolabeled fragment of the IG7 gene to control for RNA loading. The densitometry measurements are a ratio of cAR1 to IG7, normalized to the wild-type Ax2 vegetative sample.
|
|
|
|---|
2, the G protein associated with the cAMP receptor cAR1 (5). This regulation is mediated by a signal transduction pathway involving G
1, Gß, and phospholipase C. Here we describe the identification of a gene with sequence similarity to phospholipase D, PldB, and present evidence that it is also involved in the quorum-sensing pathway. Cells lacking pldB are able to aggregate at low cell density, thus bypassing the requirement for CMF. Cells overexpressing pldB are unable to aggregate at high cell density. In fact, while adding CMF to wild-type cells allows aggregation at low cell density, adding CMF to pldB-overexpressing cells has no effect, demonstrating that they are insensitive to CMF. Taken together, these two observations suggest that pldB is a negative regulator of quorum sensing in the CMF responsive pathway. Thus, we hypothesize that in wild-type cells, the presence of CMF triggers a decrease in PldB activity, which then allows cells to aggregate.
In addition to allowing cells to aggregate in suboptimal concentrations of CMF, loss of pldB also accelerates the developmental program. In both submerged monolayer conditions and on filter pads, pldB cells aggregate well before wild-type cells. Interestingly, this developmental phenotype is not seen in other mutants, such as G
1 cells, or drug treatments, such as addition of protein kinase C activators, which cause aggregation at low cell density (5; unpublished data). This argues that pldB may also be playing a role in aggregation or development that is outside of the previously described CMF pathway.
To address the rapid development phenotype observed in pldB cells, we examined the expression patterns of the early development genes cAR1, CRAC, and ACA to uncover the cause of the accelerated development phenotype of pldB cells. These genes perform indispensable roles in the cAMP signaling pathway responsible for aggregation. While there is no apparent difference in expression of CRAC and ACA between wild-type and pldB cells, cAR1 is expressed earlier and at higher levels in pldB cells than in wild-type cells. pldB cells may respond to extracellular cAMP earlier and thus initiate development earlier. These data indicate that altered cAR1 expression is likely one of the factors that cause the rapid development of pldB cells, suggesting that PldB plays a role in the timing of development.
Sequence analysis suggests that PldB belongs to the phospholipase D family of enzymes. Specifically, it contains all of the PLD conserved regions including a PH domain, CRI to CRIV, a loop, and a C-terminal domain, which suggests that PldB belongs to the PLD1 subfamily (12, 26). One of the more interesting aspects of the structure of PldB is the PH domain. PH domains are best known as phospholipid binding domains, but they have also been shown to be involved in binding to the ß
-subunits of heterotrimeric G proteins and protein kinase C (27, 44). In Dictyostelium cells, the PH domains of CRAC and protein kinase B are believed to be responsible for translocating these proteins to the plasma membrane during chemotaxis (17, 18, 32). It has been suggested that the selective localization of such PH-containing proteins to the leading edge of the cell is what allows a directional response to a chemoattractant (10, 33). Specifically, it is proposed that the localized activities of phosphatidylinositol 3-kinase and PTEN cause the accumulation of phosphatidylinositol-(3,4,5)-triphosphate at the leading edge, forming binding sites for PH-domain-containing proteins (17, 19). It is therefore feasible that the PH domain of PldB also allows it to be localized to the leading edge of a chemotaxing cell. This would in turn cause PldB activity, in the form of phosphatidic acid (PA) production, to be concentrated at the leading edge. It has been shown that PA is a regulator of RGS activity. Specifically, mammalian RGS4 is inhibited by phosphatidic acid (PA) (31). RGS proteins act as GTPase-activating proteins for heterotrimeric G proteins. We showed previously that CMF controls the GTPase activity of G
2 (4). The effect of CMF on GTPase activity is indirect and involves a G protein-coupled signal transduction pathway (5). An RGS protein is most likely directly responsible for controlling GTPase. This RGS protein could be regulated by PA produced by PldB. Therefore, PldB, through localization provided by its PH domain, could be involved in the localized regulation of G
2, the G protein mediating cAMP chemotaxis. This is especially intriguing given that G proteins in chemotaxing cells are evenly distributed along the membrane (23). Localized control of G protein activity could help to influence the polarization of a chemotaxing cell. In such a scenario, CMF would decrease PldB association with the membrane, leading to decreased PA production. This would consequently decrease RGS activity, allowing increased signaling through G
2.
In mammalian cells, PLD1 has been implicated in a number of cellular processes including Golgi function (2), clathrin coat assembly in endosomes and lysosomes (1), vesicle-dependent secretion (43), and the production of phosphatidic acid as a second messenger. It is reasonable to believe that PldB may also function in these processes in Dictyostelium. Interestingly, pldB disruptants exhibit phenotypes that suggest the disruption of one of these cellular pathways. Given the genetic pliability of D. discoideum, we are now in a position to uncover many other roles of PLD that are not easily identifiable in mammalian systems.
This work was supported by NIGMS grant S06-GM606564 from the National Institutes of Health and grant 0346975 from the National Science Foundation. The infrastructure and instrumentation of the Biological Sciences Department at Hunter are supported by Research Centers in Minority Institutions Award RR-03037 from the National Center for Research Resources of the National Institutes of Health.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»